← Open Payments lookup

KATHRINE LOHRFINK: Open Payments

NPI 1285996405 · CENTRAL POINT, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,571 in 10 payments from 6 companies in 2025. Trend: 2023 $326 · 2024 $453 · 2025 $2,571

Consulting: $2,300Food & beverage: $271
CompanyPaymentsAmount
Eli Lilly and Company2$2,300
Novo Nordisk Inc2$64
Regeneron Healthcare Solutions, Inc.2$62
Takeda Pharmaceuticals U.S.A., Inc.1$61
Madrigal Pharmaceuticals2$54
GlaxoSmithKline, LLC.1$30

Products named: ZEPBOUND, DUPIXENT, GLASSIA, REZDIFFRA, NUCALA, Rybelsus.

Industry payments across OR — which companies pay providers there.